NM_001099404.2:c.1890+50C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001099404.2(SCN5A):​c.1890+50C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00176 in 1,488,466 control chromosomes in the GnomAD database, including 45 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 28 hom., cov: 32)
Exomes 𝑓: 0.00090 ( 17 hom. )

Consequence

SCN5A
NM_001099404.2 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.108

Publications

1 publications found
Variant links:
Genes affected
SCN5A (HGNC:10593): (sodium voltage-gated channel alpha subunit 5) The protein encoded by this gene is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. This protein is found primarily in cardiac muscle and is responsible for the initial upstroke of the action potential in an electrocardiogram. Defects in this gene have been associated with long QT syndrome type 3 (LQT3), atrial fibrillation, cardiomyopathy, and Brugada syndrome 1, all autosomal dominant cardiac diseases. Alternative splicing results in several transcript variants encoding different isoforms. [provided by RefSeq, May 2022]
SCN5A Gene-Disease associations (from GenCC):
  • Brugada syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Brugada syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Laboratory for Molecular Medicine, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • dilated cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • dilated cardiomyopathy 1E
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • sick sinus syndrome 1
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • progressive familial heart block, type 1A
    Inheritance: SD, AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
  • atrial standstill
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial sick sinus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • paroxysmal familial ventricular fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive familial heart block
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • short QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 3-38603662-G-A is Benign according to our data. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38603662-G-A is described in CliVar as Likely_benign. Clinvar id is 257438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00924 (1407/152302) while in subpopulation AFR AF = 0.0321 (1333/41578). AF 95% confidence interval is 0.0306. There are 28 homozygotes in GnomAd4. There are 667 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 28 SD,AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN5ANM_001099404.2 linkc.1890+50C>T intron_variant Intron 12 of 27 ENST00000413689.6 NP_001092874.1 Q14524H9KVD2
SCN5ANM_000335.5 linkc.1890+50C>T intron_variant Intron 12 of 27 ENST00000423572.7 NP_000326.2 Q14524-2Q86V90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN5AENST00000413689.6 linkc.1890+50C>T intron_variant Intron 12 of 27 5 NM_001099404.2 ENSP00000410257.1 H9KVD2
SCN5AENST00000423572.7 linkc.1890+50C>T intron_variant Intron 12 of 27 1 NM_000335.5 ENSP00000398266.2 Q14524-2

Frequencies

GnomAD3 genomes
AF:
0.00923
AC:
1404
AN:
152184
Hom.:
28
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0321
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00353
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00291
AC:
482
AN:
165830
AF XY:
0.00224
show subpopulations
Gnomad AFR exome
AF:
0.0323
Gnomad AMR exome
AF:
0.00136
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000855
Gnomad OTH exome
AF:
0.00158
GnomAD4 exome
AF:
0.000903
AC:
1207
AN:
1336164
Hom.:
17
Cov.:
30
AF XY:
0.000801
AC XY:
521
AN XY:
650602
show subpopulations
African (AFR)
AF:
0.0329
AC:
986
AN:
29928
American (AMR)
AF:
0.00175
AC:
49
AN:
28058
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19446
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38538
South Asian (SAS)
AF:
0.0000478
AC:
3
AN:
62722
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45184
Middle Eastern (MID)
AF:
0.00321
AC:
14
AN:
4358
European-Non Finnish (NFE)
AF:
0.0000389
AC:
41
AN:
1052882
Other (OTH)
AF:
0.00207
AC:
114
AN:
55048
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
58
116
173
231
289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00924
AC:
1407
AN:
152302
Hom.:
28
Cov.:
32
AF XY:
0.00896
AC XY:
667
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0321
AC:
1333
AN:
41578
American (AMR)
AF:
0.00353
AC:
54
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68010
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
66
131
197
262
328
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00774
Hom.:
2
Bravo
AF:
0.0104
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 16, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
4.5
DANN
Benign
0.49
PhyloP100
0.11
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9827213; hg19: chr3-38645153; API